General Dermatology

Dermatology Times is recapping our exclusive expert interviews from the month of November.

At Elevate-Derm, Shanna Miranti, MPAS, PA-C, and Larissa Schmidt, DPM, outlined how interdisciplinary education, shared therapeutic advances, and evolving career pathways are strengthening the connection between dermatology and podiatry.

This review of the latest dermatologic studies highlights new research from this week, including immune checkpoint inhibitors in acral melanoma, the link between skin microbiota and asthma, a novel peptide–hyaluronic acid lip serum, and more.

Tono Health revolutionizes virtual dermatology by enhancing specialist access for HS and oncodermatology care, while prioritizing the doctor-patient relationship.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the phase 2/3 research on VDPHL01, new data on the DecisionDx-Melanoma GEP test, roflumilast's sNDA for pediatric plaque psoriasis, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore the latest advancements and expert insights from ISDS 2025 held in New York, New York.

Mondana Ghias, MD, FAAD, discusses Tono Health's role in improving access to skin care for patients of color, addressing systemic barriers and enhancing diagnostic accuracy.

Massimo Gadina, PhD, underscored the need for genetics-guided patient selection to improve treatment specificity in inflammatory skin diseases.

At Elevate-Derm Fall, Ted Rosen, MD, detailed how rapidly evolving resistance in bacteria, fungi, viruses, and more is reshaping therapeutic choices.

Dupilumab clears AD clinically and histologically, but deep immune profiling shows disease-memory T cells persist in the skin.

Stacey Swinehart, DNP, FNP-BC, DCNP, CNL, shares key takeaways for clinicians from the SDNP's recent webinar on detecting intimate partner violence among patients.

Benjamin Ungar, MD, shares groundbreaking insights on seborrheic dermatitis and emerging treatments in dermatology at ISDS 2025.

A recent survey reveals patients prioritize board-certified dermatologists and increasingly favor teledermatology for faster, accessible care.

Neuroimmune modulation, including vagus nerve stimulation, is highlighted as a promising strategy for patients unresponsive to biologics.

Explore how skin aging and cellular senescence impact overall health, revealing insights into anti-aging strategies and cosmetic conundrums.

Kilian Eyerich, MD, PhD, argues that classifying skin diseases by immune response patterns offers clearer therapeutic guidance than traditional morphology.

Discover how viral skin care trends on social media mislead users, compromising skin health, and learn evidence-based strategies for effective care from Nerissa Prieto, MD.

At Elevate-Derm Fall, Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP, outlined practical ways dermatology clinicians can incorporate psychodermatology principles and previewed the upcoming Psych and Skin video series.

Michael Rosenblum’s team identified a previously underappreciated fibroblast subset that actively regulates inflammation, fibrosis, and microbial containment in the skin.

Therapeutic modulation of mitochondria offers a pathway to control multiple cytokine pathways simultaneously.

Chronic itching can reflect systemic disease, highlighting the importance of comprehensive assessment.

Kim explores the significance of inflammation in dermatology, revealing its connections to various diseases and the importance of focused research.

Shannon Trotter, DO, and Renata Block, DMSc, MMS, PA-C, discuss social media's impact on dermatology, highlighting trends, misinformation, and the need for clinician engagement.